Daily as of 3 Nov 16:00 ET
- Price
- below both $29.71 vs 50 $33.61 / 200 $32.69
- Projection
- 💀Death cross projected in 5 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 27 Aug 2025 · projected 12 bars out · tested 8 bars
CLDX | Celldex TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$29.71
+$0.67 (+2.31%)
Celldex Therapeutics (CLDX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Aug 2025, but the two have been closing on each other and a death cross is projected within 10 bars. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $30.10 vs 50 $31.49 / 200 $31.32
- Projection
- 💀Death cross estimated 15+ weeks out
- Test
- Active cross test, 1 bar at the 200, 6 bars left
- Last cross
- 🟨Golden cross week of 19 Oct 2026 · projected 23 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $29.71 vs 50 $29.89 / 200 $35.64
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 6 Oct 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| week of 19 Oct 2026 | 🟨Golden moderate | weekly | 23 bars out | Active Cross Test |
| 6 Oct 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| 10 Mar 2026 | 🟨Golden | 4-hour | 19 bars out | Not tested |
| 3 Feb 2026 | 💀Death | 4-hour | 14 bars out | Not tested |
| 27 Aug 2025 | 🟨Golden moderate | daily | 12 bars out | 8 bar cross test |
About CLDX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$33.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid